Stockscreener 앱 받기
6.66
0.30%
-0.02
시간 외 거래:
6.66
전일 마감가:
$6.68
열려 있는:
$6.9
하루 거래량:
703.08K
Relative Volume:
0.88
시가총액:
$332.29M
수익:
-
순이익/손실:
$-52.07M
주가수익비율:
-32.07
EPS:
-0.2077
순현금흐름:
$-44.93M
1주 성능:
+12.69%
1개월 성능:
+12.31%
6개월 성능:
-20.24%
1년 성능:
-31.90%
1일 변동 폭
$6.56
$7.06
1주일 범위
$5.695
$7.06
52주 변동 폭
$4.81
$10.73
Cybin Inc Stock (CYBN) Company Profile
명칭
Cybin Inc
전화
908 764 8385
주소
100 King Street West, Suite 5600, Toronto
CYBN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CYBN
Cybin Inc
|
6.66 | 333.29M | 0 | -52.07M | -44.93M | -0.2077 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cybin Inc Stock (CYBN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-13 | 개시 | Guggenheim | Buy |
| 2021-11-19 | 다운그레이드 | Maxim Group | Buy → Hold |
Cybin Inc 주식(CYBN)의 최신 뉴스
Liquidity Mapping Around (CYBN) Price Events - news.stocktradersdaily.com
Cybin (OTCMKTS:CYBN) Trading 5.5% HigherShould You Buy? - MarketBeat
What drives Cybin Inc stock priceQuarterly Earnings Review & Small Budget Investment Growth - earlytimes.in
Wall Street Analysts Think Cybin Inc. (CYBN) Could Surge 988.67%: Read This Before Placing a Bet - MSN
Cybin taps Thermo Fisher for U.S. manufacturing of CYB003 - MSN
Cybin (OTCMKTS:CLXPF) Shares Up 5.7%Time to Buy? - MarketBeat
Earnings Beat: Why Cybin Inc stock could be next big winnerMarket Risk Summary & Low Volatility Stock Suggestions - BỘ NỘI VỤ
Will Cybin Inc. stock benefit from automationEarnings Beat & High Accuracy Swing Trade Signals - Newser
Will Cybin Inc. (R7E) stock outperform value peersStop Loss & Stepwise Swing Trade Plans - Newser
Is Cybin Inc. (R7E) stock a good hedge against inflation2025 Performance Recap & AI Driven Stock Reports - Newser
Cybin (NYSEAMERICAN:CYBN) Stock Price Expected to Rise, Guggenheim Analyst Says - MarketBeat
Can Cybin Inc. (R7E) stock attract ESG investmentsTrade Risk Summary & Reliable Entry Point Trade Alerts - Newser
How geopolitical risks impact Cybin Inc. (R7E) stockJuly 2025 Rallies & Real-Time Volume Analysis - Newser
Cybin price target raised to $48 from $39 at Guggenheim - MSN
Is Cybin Inc. stock overvalued by current metricsJuly 2025 Big Picture & Weekly Market Pulse Updates - Newser
Guggenheim Maintains Cybin (CYBN) Buy Recommendation - Nasdaq
Guggenheim Raises Price Target for Cybin (CYBN) to $48.00 | CYBN Stock News - GuruFocus
Guggenheim raises Cybin stock price target to $48 on clinical progress - Investing.com Australia
Guggenheim raises Cybin stock price target to $48 on clinical progress By Investing.com - Investing.com South Africa
Can Cybin Inc. Common Shares stock sustain free cash flowQuarterly Risk Review & Daily Oversold Bounce Ideas - Newser
Cybin (NYSEAMERICAN:CYBN) Trading Down 8.2%Here's Why - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Will Cybin Inc. Common Shares stock test record highs in 2025Earnings Trend Report & Weekly Stock Breakout Alerts - Newser
Why Cybin Inc. Common Shares stock could be top winnerTrade Risk Summary & Real-Time Chart Pattern Alerts - Newser
Cybin price target lowered to $55 from $150 at H.C. Wainwright - MSN
Bronstein, Gewirtz & Grossman, LLC Encourages Cybin Inc. (CYBN) S - The National Law Review
Why Cybin Inc. stock could be next big winnerQuarterly Profit Report & Accurate Entry and Exit Point Alerts - BỘ NỘI VỤ
Cybin Announces Up to USD$35 Million At-The-Market Equity Program - Investing News Network
Cybin Secures $175 Million in Direct Offering to Advance Clinical Programs - MSN
[6-K] CYBIN INC. Current Report (Foreign Issuer) | CYBN SEC FilingForm 6-K - Stock Titan
Understanding Momentum Shifts in (CYBN) - news.stocktradersdaily.com
Will Cybin Inc. stock gain from government policiesJuly 2025 EndofMonth & Weekly Top Gainers Alerts - newser.com
Cybin Inc (CYBN) Q2 2026 Earnings Call Highlights: Strategic Advancements Amid Financial Challenges By GuruFocus - Investing.com Canada
Cybin Inc (CYBN) Q2 2026 Earnings Call Highlights: Strategic Advancements Amid Financial Challenges - GuruFocus
Canaccord Genuity Maintains Cybin (CYBN) Buy Recommendation - Nasdaq
Cybin (CYBN) Analyst Rating Update: Canaccord Genuity Lowers PT to $45 | CYBN Stock News - GuruFocus
Canaccord Genuity lowers Cybin stock price target to $45 on dilution - Investing.com Australia
Canaccord Genuity lowers Cybin stock price target to $45 on dilution By Investing.com - Investing.com South Africa
Cybin price target lowered to $45 from $70 at Canaccord - TipRanks
Can Cybin Inc. stock deliver surprise earnings beatQuarterly Performance Summary & Precise Swing Trade Alerts - newser.com
What’s the recovery path for long term holders of Cybin Inc.Index Update & Consistent Growth Equity Picks - newser.com
Why Cybin Inc. Common Shares stock is a strong analyst pickEarnings Growth Report & Stepwise Swing Trade Plans - newser.com
Is Cybin Inc. Common Shares stock positioned for digital growth eraJuly 2025 Analyst Calls & Proven Capital Preservation Methods - newser.com
What market sentiment indicators show for Cybin Inc. Common Shares stockTrade Risk Assessment & Low Volatility Stock Suggestions - newser.com
How reliable is Cybin Inc. (R7E) stock dividend growthGap Down & Long-Term Capital Growth Strategies - newser.com
Will Cybin Inc. Common Shares stock remain on Wall Street radarJuly 2025 Drop Watch & Low Drawdown Investment Strategies - newser.com
Will Cybin Inc. stock gain from strong economyStop Loss & Expert Verified Movement Alerts - newser.com
Price momentum metrics for Cybin Inc. explainedJuly 2025 Closing Moves & Technical Analysis for Trade Confirmation - newser.com
Cybin Inc (CYBN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.36%
1.12%
자본화:
|
볼륨(24시간):